FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2924468900> ?p ?o ?g. }

• W2924468900 abstract "Cytogenetic abnormalities and mutated genes indicate the role of consolidation therapy with hematopoietic stem cell transplantation (HSCT) or chemotherapy in acute myeloid leukemia (AML). In this study, we conducted a retrospective study in adult AML patients with newly diagnosed with de novo AML who did not undergo HSCT, to study long term relapse free survival (RFS) and overall survival (OS) after consolidation chemotherapy.We recruited 141 consecutive AML patients during January 2010-June 2017, the patients received induction chemotherapy with standard dose Ara-C and Idarubicin (7 + 3 or 5 + 2 regimen) followed by intermediate (IDAC) or high dose Ara-c (HiDAC) consolidation therapy.Normal karyotype, complex, favorable, intermediate and adverse chromosomal aberrations were found in 59%, 16%, 5%, 14% and 6%, respectively. Mutated NPM1, FLT3-ITD and CEBPA genes in CN-AML were seen in 33%, 18% and 19%, respectively. A 5 year follow up, 5y-RFS was 16% and 5y-OS was 14% in the whole study population. 5y-RFS and 5y-OS in patients completed 4 cycles of consolidation therapy were 25% and 40%, respectively. Adverse cytogenetic risk and mutated FLT3-ITD were significantly associated with poor RFS (9 and 15 months, respectively) and OS (14 and 16 months, respectively), whereas patients with mutant NPM1 had favorable outcomes (RFS/OS = 51/63 months). Patients receiving 4 cycles of consolidation therapy had significantly impacts on median RFS and OS compared with those treated with 1 or 2 cycles; 15 versus 11 months (p = 0.006) and 31 versus 15 months (p < 0.001), respectively.Cytogenetic and mutation tests for FLT3-ITD, NPM1 and CEBPA genes were meaningful for predicting outcomes in adult AML patients. Adverse cytogenetic abnormalities and FLT3-ITD mutation showed dismal RFS and OS." @default.
• W2924468900 created "2019-04-01" @default.
• W2924468900 creator A5009864755 @default.
• W2924468900 creator A5013765426 @default.
• W2924468900 creator A5024268818 @default.
• W2924468900 creator A5025225823 @default.
• W2924468900 creator A5029031818 @default.
• W2924468900 creator A5035725361 @default.
• W2924468900 creator A5038277854 @default.
• W2924468900 creator A5040263004 @default.
• W2924468900 creator A5044686822 @default.
• W2924468900 creator A5069736362 @default.
• W2924468900 creator A5071698804 @default.
• W2924468900 creator A5088129898 @default.
• W2924468900 date "2019-01-30" @default.
• W2924468900 modified "2023-10-12" @default.
• W2924468900 title "Cytogenetics and FLT3-ITD mutation predict clinical outcomes in non transplant patients with acute myeloid leukemia" @default.
• W2924468900 cites W139603322 @default.
• W2924468900 cites W1534965621 @default.
• W2924468900 cites W1639111174 @default.
• W2924468900 cites W1989604472 @default.
• W2924468900 cites W1990211056 @default.
• W2924468900 cites W2035543326 @default.
• W2924468900 cites W2041027929 @default.
• W2924468900 cites W2043216151 @default.
• W2924468900 cites W2055596077 @default.
• W2924468900 cites W2063107989 @default.
• W2924468900 cites W2077194887 @default.
• W2924468900 cites W2108718836 @default.
• W2924468900 cites W2115707319 @default.
• W2924468900 cites W2127738065 @default.
• W2924468900 cites W2139778721 @default.
• W2924468900 cites W2144274033 @default.
• W2924468900 cites W2144395887 @default.
• W2924468900 cites W2148047805 @default.
• W2924468900 cites W2148883973 @default.
• W2924468900 cites W2153953632 @default.
• W2924468900 cites W2162806047 @default.
• W2924468900 cites W2167638087 @default.
• W2924468900 cites W2171383975 @default.
• W2924468900 cites W2253167439 @default.
• W2924468900 cites W2532173015 @default.
• W2924468900 cites W2559537906 @default.
• W2924468900 cites W2567727571 @default.
• W2924468900 cites W2786431998 @default.
• W2924468900 cites W2795669086 @default.
• W2924468900 cites W2899989228 @default.
• W2924468900 cites W2902063722 @default.
• W2924468900 doi "https://doi.org/10.1186/s40164-019-0127-z" @default.
• W2924468900 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6354374" @default.
• W2924468900 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30729065" @default.
• W2924468900 hasPublicationYear "2019" @default.
• W2924468900 type Work @default.
• W2924468900 sameAs 2924468900 @default.
• W2924468900 citedByCount "14" @default.
• W2924468900 countsByYear W29244689002019 @default.
• W2924468900 countsByYear W29244689002020 @default.
• W2924468900 countsByYear W29244689002021 @default.
• W2924468900 countsByYear W29244689002022 @default.
• W2924468900 crossrefType "journal-article" @default.
• W2924468900 hasAuthorship W2924468900A5009864755 @default.
• W2924468900 hasAuthorship W2924468900A5013765426 @default.
• W2924468900 hasAuthorship W2924468900A5024268818 @default.
• W2924468900 hasAuthorship W2924468900A5025225823 @default.
• W2924468900 hasAuthorship W2924468900A5029031818 @default.
• W2924468900 hasAuthorship W2924468900A5035725361 @default.
• W2924468900 hasAuthorship W2924468900A5038277854 @default.
• W2924468900 hasAuthorship W2924468900A5040263004 @default.
• W2924468900 hasAuthorship W2924468900A5044686822 @default.
• W2924468900 hasAuthorship W2924468900A5069736362 @default.
• W2924468900 hasAuthorship W2924468900A5071698804 @default.
• W2924468900 hasAuthorship W2924468900A5088129898 @default.
• W2924468900 hasBestOaLocation W29244689001 @default.
• W2924468900 hasConcept C104317684 @default.
• W2924468900 hasConcept C126322002 @default.
• W2924468900 hasConcept C143998085 @default.
• W2924468900 hasConcept C194409129 @default.
• W2924468900 hasConcept C2483381 @default.
• W2924468900 hasConcept C2776611710 @default.
• W2924468900 hasConcept C2776694085 @default.
• W2924468900 hasConcept C2777408962 @default.
• W2924468900 hasConcept C2778041864 @default.
• W2924468900 hasConcept C2778336483 @default.
• W2924468900 hasConcept C2778729363 @default.
• W2924468900 hasConcept C2779117419 @default.
• W2924468900 hasConcept C2911091166 @default.
• W2924468900 hasConcept C30481170 @default.
• W2924468900 hasConcept C45091340 @default.
• W2924468900 hasConcept C501734568 @default.
• W2924468900 hasConcept C53226629 @default.
• W2924468900 hasConcept C55493867 @default.
• W2924468900 hasConcept C71924100 @default.
• W2924468900 hasConcept C86803240 @default.
• W2924468900 hasConceptScore W2924468900C104317684 @default.
• W2924468900 hasConceptScore W2924468900C126322002 @default.
• W2924468900 hasConceptScore W2924468900C143998085 @default.
• W2924468900 hasConceptScore W2924468900C194409129 @default.
• W2924468900 hasConceptScore W2924468900C2483381 @default.
• W2924468900 hasConceptScore W2924468900C2776611710 @default.
• W2924468900 hasConceptScore W2924468900C2776694085 @default.

• next